- Home
- LCFY vs CNSP Comparison
LCFY vs CNSP Comparison
Compare LCFY & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- CNSP
- Stock Information
- Founded
- LCFY 2009
- CNSP 2017
- Country
- LCFY Australia
- CNSP United States
- Employees
- LCFY N/A
- CNSP N/A
- Industry
- LCFY
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- CNSP Health Care
- Exchange
- LCFY Nasdaq
- CNSP Nasdaq
- Market Cap
- LCFY 3.7M
- CNSP 5.6M
- IPO Year
- LCFY 2022
- CNSP 2019
- Fundamental
- Price
- LCFY $5.42
- CNSP $0.94
- Analyst Decision
- LCFY
- CNSP Hold
- Analyst Count
- LCFY 0
- CNSP 1
- Target Price
- LCFY N/A
- CNSP N/A
- AVG Volume (30 Days)
- LCFY 4.9M
- CNSP 213.4K
- Earning Date
- LCFY 07-07-2025
- CNSP 08-13-2025
- Dividend Yield
- LCFY N/A
- CNSP N/A
- EPS Growth
- LCFY N/A
- CNSP N/A
- EPS
- LCFY N/A
- CNSP N/A
- Revenue
- LCFY $2,668,385.00
- CNSP N/A
- Revenue This Year
- LCFY N/A
- CNSP N/A
- Revenue Next Year
- LCFY N/A
- CNSP N/A
- P/E Ratio
- LCFY N/A
- CNSP N/A
- Revenue Growth
- LCFY N/A
- CNSP N/A
- 52 Week Low
- LCFY $2.28
- CNSP $0.73
- 52 Week High
- LCFY $13.98
- CNSP $148.00
- Technical
- Relative Strength Index (RSI)
- LCFY 55.67
- CNSP 47.19
- Support Level
- LCFY $5.16
- CNSP $0.73
- Resistance Level
- LCFY $13.98
- CNSP $1.03
- Average True Range (ATR)
- LCFY 1.03
- CNSP 0.08
- MACD
- LCFY 0.35
- CNSP 0.02
- Stochastic Oscillator
- LCFY 23.53
- CNSP 56.67
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.